Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients.

Abstract : Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before percutaneous coronary intervention (PCI) in elective and non-ST segment elevation myocardial infarction (NSTEMI) patients. The aim of this study was to assess outcomes after performing PCI immediately after coronary angiography with an exclusive "on-the-table" P2Y12 inhibitor loading dose, by evaluating ischemic and bleeding complications in unselected patients.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.umontpellier.fr/hal-01843141
Contributeur : Dominique Mornet <>
Soumis le : mercredi 18 juillet 2018 - 15:24:33
Dernière modification le : vendredi 9 août 2019 - 13:02:03

Identifiants

  • HAL Id : hal-01843141, version 1
  • PUBMED : 30012889

Collections

Citation

Benoit Lattuca, David Belardi, Christophe Demattei, Laurent Schmutz, Luc Cornillet, et al.. Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients.. Journal of Invasive Cardiology, Health Management Publications, Inc., 2018. ⟨hal-01843141⟩

Partager

Métriques

Consultations de la notice

287